Latest Us Market News

Flight Centre Travel Group reported a record $24.5 billion in total transaction value for FY25, yet underlying profit before tax declined nearly 10%, impacted by geopolitical and regional challenges. The company declared a fully franked 29-cent final dividend and outlined strategic investments in AI, digital transformation, and the cruise sector.

Kip McGrath Education Centres Limited reported modest revenue growth and a solid increase in EBITDA for FY25, despite a significant net loss driven by its exit from the US market. The company declared a fully franked final dividend, signaling confidence in its refocused core business.

Beforepay Group Limited reported a strong FY25 with a 29% increase in net transaction margin and 14% revenue growth, driven by expanding user numbers and advances. The company continues to leverage AI-driven risk management while maintaining its ethical lending model.

Beforepay Group Limited reported a robust 74.5% increase in net profit after tax to $6.7 million for FY25, driven by growth in its core Pay Advance business, the launch of a Personal Loan product, and expansion of its AI-powered credit analytics division, Carrington Labs, in the US.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Acusensus Limited reported a robust FY25 with 20% revenue growth and a significant 84% jump in total contract value, setting the stage for an ambitious FY26 forecast of up to 41% revenue increase.

Pointerra Limited reported a strong FY25 with revenue up 45% to A$11 million and a significant reduction in net loss by 68%, driven by scalable SaaS growth and key US contract wins.

Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Rubicon Water reported a record FY25 revenue of A$69.1 million, driven by strong growth in the US and Rest of World markets, while reducing its net loss and building a robust project pipeline for FY26.

Rubicon Water’s FY25 results reveal strong global revenue growth led by the US and EMEA, alongside a narrowing EBITDA loss despite operational headwinds and strategic restructuring in China.

Reece Limited reported a 20% decline in EBIT for FY25, reflecting soft demand in both ANZ and US markets despite strategic branch expansions and acquisitions.